(CercleFinance.com) – Bruno le Maire, Minister of the Economy, Finance and Industrial and Digital Sovereignty, announces that he is pleased with GSK’s decision to invest up to 350ME on the Evreux site for production of a new low-carbon formulation of Ventolin.
The ministry’s press release recalls that half of the GSK laboratory’s emissions are generated by their metered-dose inhaler, Ventolin.
The new low-carbon formulation of Ventolin is currently in clinical trials with the potential to reduce the carbon footprint of this drug by approximately 90%.
This investment of up to 350ME by the end of 2025 includes the installation of three production lines dedicated to the production of the new low-carbon formulation of Ventolin.
Copyright © 2023 CercleFinance.com. All rights reserved.
Did you like this article ? Share it with your friends using the buttons below.
